Sponsors Seeing Subtle Differences With US FDA Meetings In Coronavirus Era

 
• By Derrick Gingery

Mass-telework is changing some meeting dynamics, like reducing the number of questions asked by agency staff.

closed-door meeting
The FDA now must conduct teleconferences with sponsors rather than in-person meetings while nearly all employees telework, which has lead to changes in the discussions. • Source: Shutterstock

More from US FDA

More from Agency Leadership